Tag: BioNTech
Pfizer-BioNTech COVID-19 vaccine gains 95% efficacy; Works well on elders
After fascinating the global healthcare community with its impressive mid-coronavirus vaccine candidate trial results which revealed 90 percent efficacy in tackling COVID-19, American-German vaccine...
Emirates prepares for global distribution of COVID-19 vaccine
Emirates Airlines, the largest airline and flag carrier in the UAE is getting ready to distribute COVID-19 vaccines worldwide. This includes the Pfizer shot...
A COVID-19 vaccine should benefit everyone; WHO Director-General
Dr. Tedros Adhanom Ghebreyesus, World Health Organisation (WHO)'s Director-General praised the rapid progress made towards a viable COVID-19 vaccine while insisting that every country...
Transportation, storage challenges could make Pfizer’s COVID-19 vaccine available only for...
When the COVID-19 vaccine from US-based Pfizer and Germany-based BioNTech starts mass production, China's Fosun Pharmaceutical Group Co. will wait to distribute it across...
Several COVID-19 vaccines could be ready by early 2021; Experts
As major drugmakers close in on the last mile with their respective final-stage trials for the proprietary coronavirus vaccine candidates, experts across the globe...
Pfizer-BioNTech has its “Eureka” moment as vaccine shows 90% efficacy
An early data set released by American-German vaccine maker duo Pfizer-BioNTech has shown that the vaccine co-developed by the team is effective against coronavirus...
Pfizer & BioNTech expand Phase 3 trials to diverse participants
The US-based pharmaceutical giants Pfizer and German biotech firm BioNTech have decided to expand their Phase 3 COVID-19 vaccine candidate trials to 44,000 participants.
The...
Our COVID-19 vaccine is “near-perfect”: BioNTech CEO
Amid slightly concerning news of AstraZeneca-Oxford vaccine trails being halted due to complications with one of the COVID-19 vaccine volunteers in the UK, CEO...
